AbbVie
ABBV
#26
Rank
ยฃ259.75 B
Marketcap
ยฃ146.84
Share price
-6.03%
Change (1 day)
4.76%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

P/S ratio for AbbVie (ABBV)

P/S ratio as of April 2025 (TTM): 6.03

According to AbbVie's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 101. At the end of 2024 the company had a P/S ratio of 5.58.

P/S ratio history for AbbVie from 2012 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20245.5810.86%
20235.042.32%
20224.9215.58%
20214.263.14%
20204.134.92%
20193.94-5.43%
20184.16-23.93%
20175.4737.85%
20163.97-4.86%
20154.17-20.04%
20145.2216.95%
20134.4651.93%
20122.94

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
2.07-65.65%๐Ÿ‡บ๐Ÿ‡ธ USA
2.33-61.32%๐Ÿ‡บ๐Ÿ‡ธ USA
14.9 147.40%๐Ÿ‡บ๐Ÿ‡ธ USA
4.81-20.23%๐Ÿ‡บ๐Ÿ‡ธ USA
4.74-21.48%๐Ÿ‡บ๐Ÿ‡ธ USA
1.89-68.68%๐Ÿ‡บ๐Ÿ‡ธ USA
1.86-69.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
3.97-34.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
4.05-32.80%๐Ÿ‡บ๐Ÿ‡ธ USA